Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT02445807

Public ClinicalTrials.gov record NCT02445807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.

Study identification

NCT ID
NCT02445807
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Promius Pharma, LLC
Industry
Enrollment
265 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2015 (Type not available)
Primary completion
Jul 2016 (Actual)
Completion
Jul 2016 (Actual)
Last update posted
May 15, 2018

2015 – 2016

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Site 101 Birmingham Alabama 35205 —
Site 103 Mobile Alabama 36608 —
Site 130 Mesa Arizona 85202 —
Site 116 Phoenix Arizona 85251 —
Site 125 Tucson Arizona 85712 —
Site 120 North Hollywood California 91606 —
Site 114 San Diego California 92117 —
Site 127 Santa Monica California 90404 —
Site 128 Clearwater Florida 33756 —
Site 115 Miami Florida 33144 —
Site 118 Indianapolis Indiana 46256 —
Site 110 Louisville Kentucky 40202 —
Site 105 Glenn Dale Maryland 20769 —
Site 111 Warren Michigan 48088 —
Site 113 Fridley Minnesota 55432 —
Site 123 Saint Joseph Missouri 64506 —
Site 106 Newington New Hampshire 03801 —
Site 104 Albuquerque New Mexico 87106 —
Site 117 Stony Brook New York 11790 —
Site 124 High Point North Carolina 27262 —
Site 109 Winston-Salem North Carolina 27157 —
Site 129 Johnston Rhode Island 02919 —
Site 119 Anderson South Carolina 29621 —
Site 102 Greenville South Carolina 29607 —
Site 108 Austin Texas 78759 —
Site 122 Houston Texas 77030 —
Site 107 Plano Texas 75024 —
Site 112 Draper Utah 84020 —
Site 126 Spokane Washington 99202 —
Site 121 Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02445807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2018 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02445807 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →